Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 37404

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid Services1,2-Stearoyl-3-trimethylammoniumpropane (DSTAP) is a cationic lipid that has been used in the formation of lipid nanoparticles (LNPs).1 Intraperitoneal administration of LNPs containing DSTAP and encapsulating resiquimod (R-848; Item No. 14806) increases peritoneal fluid levels of IFN-α, the number of tumor-associated CD8+ T cells, and reduces peritoneal tumor luminescence in a CT26-luc colorectal cancer mouse model of colorectal cancer with peritoneal metastases.
WARNING This product is not for human or veterinary use.
1. Liposomal resiquimod for enhanced immunotherapy of peritoneal metastases of colorectal cancer. Pharmaceutics 13(10), 1696 (2021).